Cingulate CING
NASDAQ CING
$5.26 +0.03 (+0.48%)
As of: Sep 22, 2026 · 11:16 AM EDT

Cingulate (CING) Receivables (2023 - 2024)

Cingulate's (CING) quarterly Receivables came in at $2247.0 in Q3 2024, down 99.86% quarter-over-quarter from $1.6 million in Q2 2024.

Analysis

Cingulate (CING) Receivables (2023 - 2024) Analysis & Trends

Cingulate (CING) has reported Receivables for 2 consecutive years, with $2247.0 the latest figure, recorded in Q3 2024.

  • For the quarter ending Q3 2024, Receivables changed N/A year-over-year to $2247.0; the trailing twelve-month figure through Sep 2024 stood at $2247.0 (changed N/A YoY), and the FY2023 full-year result was $14622.0, changed N/A from the prior year.
  • Receivables fell to $2247.0 in Q3 2024 per CING's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Receivables topped out at $1.6 million in Q2 2024 and bottomed at $2247.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 19.05 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 13.82 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 9.64 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 12.49 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 10.66 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 10.13 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 1.06 Bn
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 2,247.00
Jun 30, 2024 1.62 Mn
Dec 31, 2023 14,622.00
API Access

Cingulate Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CING&period=max&api_key=YOUR_API_KEY